Missing/wrong data?
Log in to edit
Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer
scientific article
Author/s
author: George Wilding, Karim Fizazi, Mitchell Gross, Cora Sternberg, Michael A. Carducci
Work details
Publication date
May 1, 2011
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.